Learn more

FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INST MOLEKULYARNOJ BIOLOGII IM V A ENGELGA

Overview
  • Total Patents
    30
  • GoodIP Patent Rank
    53,127
  • Filing trend
    0.0%
About

FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INST MOLEKULYARNOJ BIOLOGII IM V A ENGELGA has a total of 30 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2015. It filed its patents most often in Russian Federation. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are CENTRAL MANCHESTER HEALTHCARE, IMMUNOSEARCH and GENEOSCOPY LLC.

Patent filings in countries

World map showing FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INST MOLEKULYARNOJ BIOLOGII IM V A ENGELGAs patent filings in countries
# Country Total Patents
#1 Russian Federation 30

Patent filings per year

Chart showing FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INST MOLEKULYARNOJ BIOLOGII IM V A ENGELGAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zasedatelev Aleksandr Sergeevich 11
#2 Nasedkina Tatyana Vasilevna 7
#3 Karpov Vadim Lvovich 5
#4 Ikonnikova Anna Yurevna 4
#5 Evgenev Mikhail Borisovich 3
#6 Gryadunov Dmitrij Aleksandrovich 3
#7 Chudinov Aleksandr Vasilevich 3
#8 Emelyanova Marina Aleksandrovna 3
#9 Belyavskij Aleksandr Vadimovich 2
#10 Chumakov Petr Mikhajlovich 2

Latest patents

Publication Filing date Title
RU2746815C1 Method for detecting antibodies - class g immunoglobulins in blood serum to pathogens of severe acute respiratory viral infections, including sars-cov-2, with simultaneous prognosis of covid-19 severity, based on hydrogel biochip
RU2741099C1 Method for identifying mutations in the gene of penicillin-binding protein 2 pena neisseria gonorrhoeae, leading to resistance to beta-lactam antibiotics, on biological microchips
RU2746816C2 Humanized mice (htnfki/htnfr2ki) on c57bi /6 genetic basis with additional capability of htnfr2 conditional removal for biomedical research
RU2708465C1 Method of detecting amyloid peptide modifications using high-specific antibodies
RU2717255C1 Nucleotide sequence optimized for expression in bacteria of consensus glycoprotein of rabies virus
RU2716589C1 Method of determining polymorphic markers in cyp2c19 and cyp2d6 genes for determining individual sensitivity to antidepressants
RU2695783C1 Method for determining polymorphic markers in slco1b1, apoe and abcb1 genes for determining individual sensitivity to statins
RU2707544C1 Genetic construct based on an optimized gene of rabies virus consensus glycoprotein for preventing rabies
RU2697096C1 Method for identification of genetic polymorphisms affecting metabolism of anticancer drugs using biological microchips
RU2708971C1 Method for producing a salt of α-d-ribofuranoso-1-phosphate or α-d-2-deoxyribofuranoso-1-phosphate
RU2686102C1 Recombinant vector for creation of plasmid genetic structures with increased duration of expression of target genes
RU2689400C1 Method of analyzing polymorphic markers in the genes vkorc1, cyp4f2, cyp2c9, cyp2c19, abcb1, itgb3 to determine individual sensitivity to anticoagulant drugs
RU2667123C1 Method for use of n,n'-bis(2,3-butadienyl)-1,4-diaminobutane dihydrochloride (mdl72.527) for suppressing replication of hepatitis c virus
RU2677293C1 Method for determining genetic determinants of resistance of the pathogen of tuberculosis to bedaquiline and linezolid
RU2674687C1 Method for analysis of somatic mutations in gnaq and gna11 genes using lna-blocking multiplex pcr and subsequent hybridization with oligonucleotide biological microchip (biochip)
RU2674338C1 Method for analysis of somatic mutations in braf, nras and kit genes using lna-blocking multiplex pcr and subsequent hybridization with oligonucleotide biological microchip (biochip)
RU2667070C1 Deoxyuridine triphosphates bound to cyanine dyes by sulfamidoalkyl linkers, for use in pcr
RU2664472C1 7-methyl-2'-deoxyguanosine hydroiodide salt as substrate for producing 2'-deoxynucleosides by method of enzyme transglycosylation
RU2667648C1 Analytical test system for determining specific patient's malignant tumour sensitivity to oncolytic biotherapy
RU2650774C1 Effective targets of rna interference in the genom of hiv-1 and dyser's substrates are used for their disorder